Idiopathic Pulmonary Fibrosis (IPF) is a progressive lung disease that primarily affects people over the age of 60. It causes scarring in the lung tissue, which gradually reduces lung capacity and makes breathing difficult. Despite years of research, the exact causes of IPF remain largely unknown, and current treatments mainly aim to slow its progression rather than reverse or cure the disease.Because IPF tends to develop later in life, researchers have long suspected a connection with biological aging. This is the focus of a recent study by scientists from Insilico Medicine. Their research, titled “AI-driven toolset for IPF and aging research associates lung fibrosis with accelerated aging,” was published recently in Aging-US, Volume 17, Issue 8.Full blog - https://aging-us.org/2025/09/ai-tools-reveal-how-ipf-and-aging-are-connected/Paper DOI - https://doi.org/10.18632/aging.206295Corresponding author - Alex Zhavoronkov - alex@insilico.comAbstract video - https://www.youtube.com/watch?v=24lX2lHbt7oSign up for free Altmetric alerts about this article - https://aging.altmetric.com/details/email_updates?id=10.18632%2Faging.206295Subscribe for free publication alerts from Aging - https://www.aging-us.com/subscribe-to-toc-alertsKeywords - aging, IPF, generative AI, transformer, proteomicsTo learn more about the journal, please visit our website at https://www.Aging-US.com​​ and connect with us on social media at:Facebook - https://www.facebook.com/AgingUS/X - https://twitter.com/AgingJrnlInstagram - https://www.instagram.com/agingjrnl/YouTube - https://www.youtube.com/@AgingJournalLinkedIn - https://www.linkedin.com/company/aging/Bluesky - https://bsky.app/profile/aging-us.bsky.socialPinterest - https://www.pinterest.com/AgingUS/Spotify - https://open.spotify.com/show/1X4HQQgegjReaf6Mozn6McMEDIA@IMPACTJOURNALS.COM